Targeting the Role of Group 1 Metabotropic Glutamate Receptors

With a $40,000 grant from FRAXA Research Foundation in 2008, Dr. Huibert Mansvelder and his team at the University of Amsterdam studied the role of different receptors and their reactions to drug compounds.

$40,000 Grant
Huibert Mansvelder, PhD
Principal Investigator

Rhiannon M. Meredith, PhD
FRAXA Postdoctoral Fellow


University of Amsterdam
2008 FRAXA Research Grant

Targeting the Role of Group 1 Metabotropic Glutamate Receptors

by Huibert Mansvelder, 5/1/2008

Our research project will firstly study patterns of activity across neuronal networks from juvenile brains of young Fmr1 KO (Fragile X) mice and measure the effects of lack of FMRP upon the functional activity of hundreds of neurons simultaneously. These patterns of neuronal activity are a key feature of newly-forming networks and depend upon glutamatergic signalling in the cortex. Metabotropic glutamate receptors (mGluRs) are already expressed in the brain before birth and a wealth of data from morphology, cellular and behavioural experiments show alterations in signalling via a particular type of these receptors, mGluR5. We will test whether application of drug compounds targeting the mGluR5 receptors during these critical early periods of network development can have a beneficial effect upon the early connectivity and function of the networks in Fmr1 KO mice. Furthermore, we will test the effects of specific mGluR drugs on activity during later periods of development.

Our aim is that the outcome of these experiments will directly assess the effects of mGluR-targeting compounds, which are potential viable candidates for clinical trials, on the function of networks of neurons during critical early periods and subsequent maturation of the brain in Fragile X.

Explore Current Fragile X Research

FRAXA-funded researchers around the world are leading the way towards effective treatments and ultimately a cure.